WuXi AppTec adopts Elsevier tech, gains access to 500m experimental details

By Melissa Fassbender

- Last updated on GMT

Elsevier’s solutions extract and index more than 500m experimental details for use by WuXi AppTec drug developers. (Image: iStock/agsandrew)
Elsevier’s solutions extract and index more than 500m experimental details for use by WuXi AppTec drug developers. (Image: iStock/agsandrew)
WuXi AppTec has adopted Elsevier’s technology as the company begins to focus less on point solutions, and more on provider partnerships, says VP of procurement.

According to the information products and services company, Elsevier, the deal sets the foundations for a long-term strategic and collaborative relationship.

Per the agreement, WuXi will use Elsevier’s Reaxys​ and Reaxys Medicinal Chemistry​ to support its synthetic chemistry and medicinal chemistry research. More than 3,500 chemists will use the tools.

"The Reaxys tools will aid WuXi’s researchers particularly in the early phases of R&D, by allowing them to rapidly identify required pieces of data efficiently – supporting more confident hit identification, lead optimization and synthesis planning. Further, the Reaxys tools are fully interoperable and integrate with the existing environment of tools and systems, saving time and reducing the risk of inconsistencies​," Timothy Hoctor, VP Professional Services, Elsevier R&D Solutions, told Outsourcing-Pharma.com.

According to the company, the five-year agreement established between the companies will also move WuXi into newer areas, such as medicinal chemistry. The agreement consists of an unlimited license for both solutions that covers all WuXi sites, which span more than 3m square feet of laboratory and manufacturing space.

As we expand our offerings, our focus is less on point solutions, and more on partnership with providers who can offer complete solutions that support a broad set of needs for our researchers across the organization​,” said Mr Lucent Lu, VP Procurement of Wuxi Apptec.

Specifically, the solutions extract and index more than 500m experimental details from more than 16,000 periodicals. Both solutions also integrate other vender technology, allowing WuXi to incorporate its own data and content.

Additionally, Hoctor explained that the solutions are designed to work the way chemists think, thus giving "intuitive access to chemistry data​."

He added, "Elsevier’s extensive heritage and expertise in organizing data through established taxonomies makes the difference; this means that the huge amounts of data the Reaxys solutions hold are easily searchable, providing the shortest path from the chemistry question asked, to insight​." 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars